# Liposomal Bupivacaine Plus Plain Bupivacaine Versus Dexamethasone Plus Plain Bupivacaine in the Supraclavicular Brachial Plexus Block in Patients With Risk Factors for Severe Acute Postoperative Pain

> **NCT07665762** · PHASE3 · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 90 (estimated)

## Conditions studied

- Pain, Postoperative
- Liposomal Bupivacaine
- Dexamethasone
- Supraclavicular Brachial Plexus Block
- High Risk Factors
- Distal Radial Fracture

## Interventions

- **DRUG:** 10ml 0.5% plain bupivacaine with 10ml 1.33% liposomal bupivacaine
- **DRUG:** 19ml 0.5% plain bupivacaine with 1ml (4mg) dexamethasone

## Key facts

- **NCT ID:** NCT07665762
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-04
- **Primary completion:** 2028-09-01
- **Final completion:** 2029-03-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07665762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07665762, "Liposomal Bupivacaine Plus Plain Bupivacaine Versus Dexamethasone Plus Plain Bupivacaine in the Supraclavicular Brachial Plexus Block in Patients With Risk Factors for Severe Acute Postoperative Pain". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07665762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*